Clinical trial
A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in…
NCT00116402 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00116402 |
|---|---|
| Title | A Pilot Study of the Mechanism of Synergism Between FP and Salmeterol in Preventing COPD Exacerbations |
| Official title | A Pilot Study of the Mechanism of Synergism Between Fluticasone (FP) and Salmeterol in Preventing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations |
| Lead sponsor | University of Chicago, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | fluticasone and salmeterol |
| Enrollment | 15 |
| Start date | Jan 1, 2005 |
| Primary completion | Sep 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Jun 29, 2005 |
| Last update posted | Aug 5, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: